Your browser doesn't support javascript.
loading
Thymidine utilisation pathway is a novel phenotypic switch of Mycoplasma hominis.
Fisunov, Gleb Yu; Pobeguts, Olga V; Ladygina, Valentina G; Zubov, Alexandr I; Galyamina, Mariya A; Kovalchuk, Sergey I; Ziganshin, Rustam K; Evsyutina, Daria V; Matyushkina, Daria S; Butenko, Ivan O; Bukato, Olga N; Veselovsky, Vladimir A; Semashko, Tatiana A; Klimina, Ksenia M; Levina, Galina A; Barhatova, Olga I; Rakovskaya, Irina V.
Afiliación
  • Fisunov GY; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Pobeguts OV; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Ladygina VG; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Zubov AI; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Galyamina MA; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Kovalchuk SI; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • Ziganshin RK; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
  • Evsyutina DV; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Matyushkina DS; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Butenko IO; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Bukato ON; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Veselovsky VA; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Semashko TA; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Klimina KM; Department of Molecular Biology and Genetics, Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
  • Levina GA; Department of Biotechnology, Vavilov Institute of General Genetics Russian Academy of Sciences, Moscow, Russia.
  • Barhatova OI; Gamaleya National Research Center of Epidemiology and Microbiology, Moscow, Russia.
  • Rakovskaya IV; Gamaleya National Research Center of Epidemiology and Microbiology, Moscow, Russia.
J Med Microbiol ; 71(1)2022 Jan.
Article en En | MEDLINE | ID: mdl-35037614
ABSTRACT
Introduction. Mycoplasma hominis is a bacterium belonging to the class Mollicutes. It causes acute and chronic infections of the urogenital tract. The main features of this bacterium are an absence of cell wall and a reduced genome size (517-622 protein-encoding genes). Previously, we have isolated morphologically unknown M. hominis colonies called micro-colonies (MCs) from the serum of patients with inflammatory urogenital tract infection.Hypothesis. MCs are functionally different from the typical colonies (TCs) in terms of metabolism and cell division.Aim. To determine the physiological differences between MCs and TCs of M. hominis and elucidate the pathways of formation and growth of MCs by a comparative proteomic analysis of these two morphological forms.Methodology. LC-MS proteomic analysis of TCs and MCs using an Ultimate 3000 RSLC nanoHPLC system connected to a QExactive Plus mass spectrometer.Results. The study of the proteomic profiles of M. hominis colonies allowed us to reconstruct their energy metabolism pathways. In addition to the already known pentose phosphate and arginine deamination pathways, M. hominis can utilise ribose phosphate and deoxyribose phosphate formed by nucleoside catabolism as energy sources. Comparative proteomic HPLC-MS analysis revealed that the proteomic profiles of TCs and MCs were different. We assume that MC cells preferably utilised deoxyribonucleosides, particularly thymidine, as an energy source rather than arginine or ribonucleosides. Utilisation of deoxyribonucleosides is less efficient as compared with that of ribonucleosides and arginine in terms of energy production. Thymidine phosphorylase DeoA is one of the key enzymes of deoxyribonucleosides utilisation. We obtained a DeoA overexpressing mutant that exhibited a phenotype similar to that of MCs, which confirmed our hypothesis.Conclusion. In addition to the two known pathways for energy production (arginine deamination and the pentose phosphate pathway) M. hominis can use deoxyribonucleosides and ribonucleosides. MC cells demonstrate a reorganisation of energy metabolism unlike TC cells, they preferably utilise deoxyribonucleosides, particularly thymidine, as an energy source rather than arginine or ribonucleosides. Thus MC cells enter a state of energy starvation, which helps them to survive under stress, and in particular, to be resistant to antibiotics.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Timidina / Mycoplasma hominis / Proteoma Límite: Humans Idioma: En Revista: J Med Microbiol Año: 2022 Tipo del documento: Article País de afiliación: Rusia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Timidina / Mycoplasma hominis / Proteoma Límite: Humans Idioma: En Revista: J Med Microbiol Año: 2022 Tipo del documento: Article País de afiliación: Rusia
...